Literature DB >> 19460601

On the relationship between meningococcal transmission dynamics and disease: remarks on humoral immunity.

Giorgio Guzzetta1, Piero Manfredi, Roberto Gasparini, Donatella Panatto, W John Edmunds.   

Abstract

We consider a model for the transmission dynamics of Neisseria meningitidis which incorporates the humoral immunity hypothesis in an explicit way. The "humoral immunity" hypothesis states that individuals will experience significantly different risks of invasive disease depending on whether they are experiencing their first infection episode, or a subsequent one. The model is fitted to the Stonehouse-Danbury carriage data and to UK disease data. For serogroup C (B) the risk of disease during the first infection episode results to be 100 (400) times higher compared to subsequent ones. Moreover the best-fit corresponds to the situation where N. lactamica essentially always confers cross-protection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19460601     DOI: 10.1016/j.vaccine.2009.01.092

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years.

Authors:  Roberto Gasparini; Maurizio Comanducci; Daniela Amicizia; Filippo Ansaldi; Paola Canepa; Andrea Orsi; Giancarlo Icardi; Emanuela Rizzitelli; Gabriella De Angelis; Stefania Bambini; Monica Moschioni; Sara Comandi; Isabella Simmini; Giueseppe Boccadifuoco; Brunella Brunelli; Marzia Monica Giuliani; Mariagrazia Pizza; Donatella Panatto
Journal:  J Clin Microbiol       Date:  2014-03-19       Impact factor: 5.948

Review 2.  Epidemiology of Neisseria meningitidis infections: case distribution by age and relevance of carriage.

Authors:  G Gabutti; A Stefanati; P Kuhdari
Journal:  J Prev Med Hyg       Date:  2015-08-31

Review 3.  Meningococcal B vaccination strategies and their practical application in Italy.

Authors:  R Gasparini; D Amicizia; P L Lai; D Panatto
Journal:  J Prev Med Hyg       Date:  2015-08-31

4.  Introducing vaccination against serogroup B meningococcal disease: an economic and mathematical modelling study of potential impact.

Authors:  Hannah Christensen; Matthew Hickman; W John Edmunds; Caroline L Trotter
Journal:  Vaccine       Date:  2013-04-06       Impact factor: 3.641

5.  Fast and accurate dynamic estimation of field effectiveness of meningococcal vaccines.

Authors:  Lorenzo Argante; Michele Tizzoni; Duccio Medini
Journal:  BMC Med       Date:  2016-06-30       Impact factor: 8.775

Review 6.  [Meningococcus B: control of two outbreaks by vaccination].

Authors:  G Gabutti
Journal:  J Prev Med Hyg       Date:  2014-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.